Insiders Trades
Medline Inc. Stock: price and insider trades · United States
US·Mcap US$48.3B
No insider purchase over the last 90 days. The latest was filed 09 Jun 2026.
Medline Inc.: what insiders have been doing
Medline Inc. is a listed company. Filings by its managers are published through SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for Medline Inc. logged 69 filings by 28 insiders.
On the market, 1 insider bought (1 purchase totalling €147k) while 5 insiders sold (22 sales totalling €4.8B). Taken together, the sales exceed the purchases by €4.8B. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Carlyle Group Inc. filed the largest sale, €921.3M, on 12 March 2026. The buyers include 1 finance chief.
Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 69 filings, this issuer sits above that mark. Since 2025, the database holds 1 purchase and 22 sales by insiders of the company. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 28.43 bn USD and net income at 1.16 bn USD.
The clock since the last published purchase (9 June 2026) now reads 130 days. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
77
Thresholds
n/a
Buy Volume
€147,016
1 ops. · all time
Sell Volume
€5B
22 ops. · all time
Who traded when
BuySaleGIC Private Ltd13 sales
BCP 8 Holdings Mozart Manager L.L.C.5 sales
BX Mozart ML-2 Holdco L.P.5 sales
Hellman & Friedman Capital Partners X (Parallel), L.P.2 sales
Carlyle Group Inc.1 sale
Carlyle Mozart Coinvestment Holdings, L.P.1 sale
+4 other insiders
Since the insiders bought
- -2.3%Entry US$36.54 · Close 13 Oct 2026 US$35.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Medline Inc. Buy (bullish), based on 26 analysts. Average price target: US$44.42.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,422 of 24,147 companies
39.8
score / 100
Value41
Quality38
FCF yld2.7%
Earn yld2.4%
EV/EBITDA19.9x
ROE4.9%
Gross mgn26%
Net mgn4.1%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$35.93
Analyst consensus
26 analystsBuy
US$34.00Target US$44.42(+24%)US$55.00
Income statement
RevenueUS$28.4B
Gross profitUS$7.5B26% margin
EBITDAUS$3.1B11% margin
Net incomeUS$1.2B2.3% margin
Valuation
PER (trailing)89.8x
PER (forward)22.8x
P/Book2.7x
Balance sheet & cash
Market capUS$48.3B
Total debtUS$12.6B
Free Cash FlowUS$1.3B
Debt / Equity66%
Profitability & ownership
ROE4.9%
ROA2.5%
% insiders0.3%
% institutions112.3%
Last declaration on 13 October 2026
Declarations77 total
7,816,987 shares@ US$35.150.57% mcap19.3% of flowClass A Common StockSEC:0001193125-26-419824:0
7,183,013 shares@ US$35.050.53% mcap21.8% of flowClass A Common StockSEC:0001193125-26-416053:4
2,570,999 shares@ US$35.350.19% mcap7.9% of flowClass A Common StockSEC:0001193125-26-416053:0
7,146,941 shares@ US$34.330.51% mcap21.3% of flowClass A Common StockSEC:0001193125-26-416053:1
1,688,690 shares@ US$35.780.13% mcap5.2% of flowClass A Common StockSEC:0001193125-26-416053:2
2,088,987 shares@ US$35.050.15% mcap6.4% of flowClass A Common StockSEC:0001193125-26-416053:3
1,500,000 shares@ US$35.800.11% mcap12.1% of flowClass A Common StockSEC:0001193125-26-354079:0
100,000 shares@ US$35.800.0076% mcap0.8% of flowClass A Common StockSEC:0001193125-26-354079:1
590,284 shares@ US$35.580.044% mcap4.7% of flowClass A Common StockSEC:0001193125-26-343561:0
500,000 shares0Class A Common StockSEC:0001104659-26-092738:0
500,000 shares0Class B Common StockSEC:0001104659-26-092738:1
1,710,907 shares@ US$35.460.13% mcap13.7% of flowClass A Common StockSEC:0001193125-26-340273:0
265,711 shares@ US$36.480.021% mcap2.2% of flowClass A Common StockSEC:0001193125-26-340273:1
271,994 shares@ US$35.330.020% mcap2.2% of flowClass A Common StockSEC:0001193125-26-340273:2
1,308 sharesClass A Common StockSEC:0001193125-26-274355:0
2,370 sharesClass A Common StockSEC:0001193125-26-274286:0
1,889 sharesClass A Common StockSEC:0001193125-26-274302:0
100,000 shares@ US$36.500.0081% mcap100.0% of flowCommonSEC144:0001628280-26-043476
10,345 shares0Class A Common StockSEC:0001193125-26-271363:0
5,387 sharesClass A Common StockSEC:0001193125-26-271363:1
5,000 shares@ US$34.150.0004% mcap100.0% of flowClass A Common StockSEC:0001193125-26-263843:0
Canonical exit: 3 Sept 2026 (T+90)
▼
Same trade as the filing by BCP 8 Holdings Mozart Manager L.L.C., counted once · View ↗
1,489,924 shares@ US$36.53752.9% of flowClass A Common StockSEC:0001193125-26-251449:3
438,214 sharesClass A Common StockSEC:0001193125-26-251451:4
438,214 sharesClass A Common StockSEC:0001193125-26-251449:4
19,712,326 shares@ US$36.537538.2% of flowClass A Common StockSEC:0001193125-26-251451:0
25 of 77 declarations
About Medline Inc.
Medline Inc. is a healthcare supplier providing a wide range of medical supplies and healthcare solutions. The company focuses on improving patient care efficiency and reducing costs for healthcare facilities.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
